Table 1.
e-Drug3D-lib | Ligand | Ciclesonide | Losartan | Telmisartan | |
Site-Specific Docking | Calculated Binding Affinity Score (kcal/mol) |
1 | −11.41 | −9.14 | −8.94 |
2 | −11.06 | −9.14 | −8.29 | ||
3 | −11.03 | −9.14 | −8.02 | ||
Blind Docking | Calculated Binding Affinity Score (kcal/mol) |
1 | −11.35 | −9.14 | −8.62 |
2 | −11.09 | −9.13 | −8.72 | ||
3 | −10.88 | −9.14 | −8.08 | ||
Drugs-lib | Ligand | Flezelastine | Hesperidin | Niceverine | |
Site-Specific Docking | Calculated Binding Affinity Score (kcal/mol) |
1 | −10.58 | −9.87 | −9.60 |
2 | −10.38 | −10.61 | −8.90 | ||
3 | −10.43 | −10.72 | −10.63 | ||
Blind Docking | Calculated Binding Affinity Score (kcal/mol) |
1 | −10.29 | −10.98 | −9.62 |
2 | −10.10 | −9.78 | −9.05 | ||
3 | −10.00 | −9.16 | −9.42 | ||
NP-lib | Ligand | NP1 | NP2 | NP3 | |
Site-Specific Docking | Calculated Binding Affinity Score (kcal/mol) |
1 | −11.73 | −10.55 | −10.28 |
2 | −10.66 | −10.37 | −10.28 | ||
3 | −10.12 | −10.47 | −10.28 | ||
Blind Docking | Calculated Binding Affinity Score (kcal/mol) |
1 | −10.43 | −10.70 | −10.28 |
2 | −10.14 | −10.84 | −10.28 | ||
3 | −10.34 | −10.65 | −10.28 |